 Z79 |
 |
Long term (current) drug therapy  |
| |
| Includes |
long term (current) drug use for prophylactic purposes
|
| CodeAlso |
any therapeutic drug level monitoring (Z51.81)
|
| Excludes2 |
drug abuse and dependence (F11-F19)
drug use complicating pregnancy, childbirth, and the puerperium (O99.32-)
|
|
| |
| Z79.0 |
|
Long term (current) use of anticoagulants and antithrombotics/antiplatelets |
| |
| Excludes2 |
long term (current) use of aspirin (Z79.82)
|
|
| |
 Z79.01 |
|
Long term (current) use of anticoagulants |
| | |
| Z79.02 |
|
Long term (current) use of antithrombotics/antiplatelets |
| |
|
| |
| |
| Z79.1 |
|
Long term (current) use of non-steroidal anti-inflammatories (NSAID) |
| |
| Excludes2 |
long term (current) use of aspirin (Z79.82)
|
| nonPrimary |
Yes
|
|
|
| |
| Z79.2 |
|
Long term (current) use of antibiotics |
| |
|
|
| |
| Z79.3 |
|
Long term (current) use of hormonal contraceptives |
| |
| Long term (current) use of birth control pill or patch |
|
|
| |
| Z79.4 |
|
Long term (current) use of insulin |
| |
| Excludes2 |
long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85)
long term (current) use of oral antidiabetic drugs (Z79.84)
long term (current) use of oral hypoglycemic drugs (Z79.84)
|
|
|
| |
| Z79.5 |
|
Long term (current) use of steroids |
| |
| Z79.51 |
|
Long term (current) use of inhaled steroids |
| |
|
| | |
| Z79.52 |
|
Long term (current) use of systemic steroids |
| |
|
| |
| |
| Z79.6 |
|
Long term (current) use of immunomodulators and immunosuppressants |
| |
| Excludes2 |
long term (current) use of steroids (Z79.5-)
long term (current) use of agents affecting estrogen receptors and estrogen levels (Z79.81-)
|
|
| |
| Z79.60 |
|
Long term (current) use of unspecified immunomodulators and immunosuppressants |
| | |
| Z79.61 |
|
Long term (current) use of immunomodulator |
| |
| Long term (current) use of apremilast | | Long term (current) use of immunomodulatory imide drug | | Long term (current) use of lenalidomide | | Long term (current) use of pomalidomide |
|
| | |
| Z79.62 |
|
Long term (current) use of immunosuppressant |
| |
| Z79.620 |
|
Long term (current) use of immunosuppressive biologic |
| |
| Long term (current) use of adalimumab | | Long term (current) use of etanercept | | Long term (current) use of infliximab | | Long term (current) use of monoclonal antibodies |
|
| | |
| Z79.621 |
|
Long term (current) use of calcineurin inhibitor |
| |
| Long term (current) use of cyclosporine | | Long term (current) use of tacrolimus |
|
| | |
| Z79.622 |
|
Long term (current) use of Janus kinase inhibitor |
| |
| Long term (current) use of tofacitinib |
|
| | |
| Z79.623 |
|
Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor |
| |
| Long term (current) use of sirolimus |
|
| | |
| Z79.624 |
|
Long term (current) use of inhibitors of nucleotide synthesis |
| |
| Long term (current) use of azathioprine | | Long term (current) use of mycophenolate | | Long term (current) use of purine synthesis (IMDH) inhibitors |
|
| | | |
| Z79.63 |
|
Long term (current) use of chemotherapeutic agent |
| |
| Z79.630 |
|
Long term (current) use of alkylating agent |
| |
| Long term (current) use of chlorambucil | | Long term (current) use of cisplatin | | Long term (current) use of cyclophosphamide |
|
| | |
| Z79.631 |
|
Long term (current) use of antimetabolite agent |
| |
| Long term (current) use of 5-fluorouracil | | Long term (current) use of 6-mercaptopurine | | Long term (current) use of cytarabine | | Long term (current) use of methotrexate |
|
| | |
| Z79.632 |
|
Long term (current) use of antitumor antibiotic |
| |
| Long term (current) use of bleomycin | | Long term (current) use of doxorubicin | | Long term (current) use of mitomycin C |
|
| | |
| Z79.633 |
|
Long term (current) use of mitotic inhibitor |
| |
| Long term (current) use of paclitaxel | | Long term (current) use of plant alkaloids | | Long term (current) use of vinblastine | | Long term (current) use of vincristine |
|
| | |
| Z79.634 |
|
Long term (current) use of topoisomerase inhibitor |
| |
| Long term (current) use of etoposide | | Long term (current) use of irinotecan | | Long term (current) use of topotecan |
|
| | | |
| Z79.64 |
|
Long term (current) use of myelosuppressive agent |
| |
| Long term (current) use of hydroxyurea |
|
| | |
| Z79.69 |
|
Long term (current) use of other immunomodulators and immunosuppressants |
| |
| |
| Z79.8 |
|
Other long term (current) drug therapy |
| |
| Z79.81 |
|
Long term (current) use of agents affecting estrogen receptors and estrogen levels |
| |
| CodeFirst |
, if applicable:
malignant neoplasm of breast (C50.-)
malignant neoplasm of prostate (C61)
|
| UseAdditionalCode |
code, if applicable, to identify:
estrogen receptor positive status (Z17.0)
family history of breast cancer (Z80.3)
genetic susceptibility to malignant neoplasm (cancer) (Z15.0-)
personal history of breast cancer (Z85.3)
personal history of prostate cancer (Z85.46)
postmenopausal status (Z78.0)
|
| Excludes1 |
hormone replacement therapy (Z79.890)
|
|
| |
| Z79.810 |
|
Long term (current) use of selective estrogen receptor modulators (SERMs) |
| |
| Long term (current) use of raloxifene (Evista) | | Long term (current) use of tamoxifen (Nolvadex) | | Long term (current) use of toremifene (Fareston) |
| nonPrimary |
Yes
|
|
| | |
| Z79.811 |
|
Long term (current) use of aromatase inhibitors |
| |
| Long term (current) use of anastrozole (Arimidex) | | Long term (current) use of exemestane (Aromasin) | | Long term (current) use of letrozole (Femara) |
| nonPrimary |
Yes
|
|
| | |
| Z79.818 |
|
Long term (current) use of other agents affecting estrogen receptors and estrogen levels |
| |
| Long term (current) use of estrogen receptor downregulators | | Long term (current) use of fulvestrant (Faslodex) | | Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist | | Long term (current) use of goserelin acetate (Zoladex) | | Long term (current) use of leuprolide acetate (leuprorelin) (Lupron) | | Long term (current) use of megestrol acetate (Megace) |
| nonPrimary |
Yes
|
|
| | | |
| Z79.82 |
|
Long term (current) use of aspirin |
| | |
| Z79.83 |
|
Long term (current) use of bisphosphonates |
| |
|
| | |
| Z79.84 |
|
Long term (current) use of oral hypoglycemic drugs |
| |
| Long term (current) use of oral antidiabetic drugs |
| Excludes2 |
long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85)
long term (current) use of insulin (Z79.4)
|
| nonPrimary |
Yes
|
|
| | |
| Z79.85 |
|
Long-term (current) use of injectable non-insulin antidiabetic drugs |
| |
| Excludes2 |
long term (current) use of insulin (Z79.4)
long term (current) use of oral hypoglycemic drugs (Z79.84)
|
|
| | |
| Z79.89 |
|
Other long term (current) drug therapy |
| |
| Z79.890 |
|
Hormone replacement therapy |
| |
|
| | |
| Z79.891 |
|
Long term (current) use of opiate analgesic |
| |
| Long term (current) use of methadone for pain management |
| Excludes1 |
methodone use NOS (F11.9-)
use of methodone for treatment of heroin addiction (F11.2-)
|
|
| | |
| Z79.899 |
|
Other long term (current) drug therapy |
| | |